Conference programme
Location: Hotel Blique by Nobis, Stockholm (Gävlegatan 18)
Friday, 31 May
10.00
12.00 – 13.00
Opening ceremony, welcome and introduction
Scientific committee:
Prof. Neil Lagali, Linköping university, Sweden;
Berit Byström, MD, Docent, University Hospital of Umeå, Sweden;
Branka Samolov, MD, PhD, S:t Erik eye hospital, Sweden;
Aniridia organizations:
Barbara Poli, President of Aniridia Europe;
Ivana Kildsgaard, President of Aniridia Sweden;
Welcome speech:
Beatrice Peebo, MD, Assist. Prof., Clinic Manager, S:t Erik eye hospital, Sweden
“Dry eye disease – myths and facts”,
Prof. Tor Paaske Utheim, MD, Oslo university hospital, Norway
Chairs: Erlend Christoffer Sommer Landsend & Dominique Bremond-Gignac
“Glaucoma in congenital aniridia. Clinical Considerations and Management”,
Amelie Botling Taube, MD, PhD, S:t Erik eye hospital, Sweden;
“Surgical management of aniridic glaucoma”,
Prof. Peter A. Netland, MD, University of Virginia School of Medicine, USA
Chairs: Peter Netland & Tor Paaske Utheim
“Aniridia and the brain”,
James Lauderdale, Assoc. Prof., University of Georgia, USA;
“Health-related quality of life in congenital aniridia”,
Erlend Christoffer Sommer Landsend, MD, PhD, Oslo university hospital, Norway;
“Aniridia stories: Investigating congenital aniridia through narrative medicine”,
Chiara Ancona, MD, University of Brescia, Italy;
“Subjective symptoms and social consequences for patients with aniridia: Results of the pan-European COST survey study”,
Renata Schoffer, MD, Region Östergötland, Sweden
Moderator: James Lauderdale
Participants: Peter Netland, Dominique Bremond-Gignac, Erlend Christoffer Sommer Landsend & Sophie Valleix
18.45
19.00
Saturday, 1 June
08.30 – 09.30
Chair: Bogumil Wowra
“Artificial iris in aniridia: A dilemma”,
Vito Romano, MD, Assoc. Prof., University of Brescia, Italy;
“Posterior segment anomalies in PAX6-related congenital aniridia”,
Prof. Dominique Bremond-Gignac, MD, University hospital Necker enfants malades, APHP, France
09.30 – 10.30
Chairs: Christina Grupcheva & Miriam Barbany Rodríguez
“Keratopathy in aniridia, clinical features and treatment options”,
Branka Samolov, MD, PhD, S:t Erik eye hospital, Sweden
& Per Montan, MD, Assist. Prof., S:t Erik eye hospital, Sweden;
“Lessons learned from a Swedish register study of aniridia”,
Berit Byström, MD, Docent, Umeå University, Sweden
& Branka Samolov, MD, PhD, S:t Erik eye hospital, Sweden;
“Outcomes of Corneal Transplantation to Treat Aniridia-Associated Keratopathy: Long Term Outcomes from UK Transplant Registry”,
Prof. Francisco Figueiredo, MD, Newcastle university, United Kingdom
11.00 – 12.00
Chairs: Stefano Ferrari & Francisco Figueiredo
“Molecular insights into aniridia-associated keratopathy”,
Berit Byström, MD, Docent, Umeå University, Sweden;
“Multi-omics analysis of aniridia stem cell-derived cornea cells”,
Dulce Lima Cunha, PhD, Radboud university, the Netherlands;
“Pluripotent stem cells as tools to study and treat limbal stem cell deficiency”,
Tanja Ilmarinen, Adj. Prof., Tampere university, Finland
12.00 – 13.30
13.30 – 14.30
Chairs: Dominique Bremond-Gignac & James Lauderdale
“Genetic diagnosis, clinical implications and patient management”,
Prof. Mariya Moosajee, MD, UCL institute of ophthalmololgy & the Francis Crick institute, United Kingdom;
“NGS, WGS, optical mapping, and Hi-C tools to solve and interpret pathogenic mechanisms of congenital iris malformations: French experience from a cohort of more than 300 families”,
Prof. Sophie Valleix, MD, University hospital Necker enfants malades, France;
“Syndromic aniridia and metabolomics”,
Prof. Mariya Moosajee, MD, UCL institute of ophthalmology & the Francis Crick institute, United Kingdom
14.30 – 15.00
Moderator: Peter Netland
Participants: Neil Lagali, Mariya Moosajee, Sophie Valleix & James Lauderdale
15.00 – 15.30
15.30 – 17.00
Chairs: Laura Mauring & Bogumil Wowra
“Management of infants and children with aniridia at a German national referral center”,
Prof. Barbara Käsmann-Kellner, MD, Saarland university, Germany;
“Corneal aspects of congenital aniridia”,
Fabian Fries, MD, Saarland university medical center, Germany;
“Management of aniridia – European guidelines”,
Prof. Dominique Bremond-Gignac, MD, University hospital Necker enfants malades, APHP, France;
“Cohort data from 319 subjects with congenital aniridia at the Schwiete Center”,
Prof. Nóra Szentmáry, MD, Saarland university medical center, Germany
17.00 – 17.30
Moderator: Bogumil Wowra
Participants: Dominique Bremond-Gignac, Erlend Christoffer Sommer Landsend, Laura Meuring & Barbara Käsmann-Kellner
19.00
Sunday, 2 June
08.30 – 10.30
Chairs: Neil Lagali & Stefano Ferrari
“Gene therapy approaches for aniridia”,
Prof. Elizabeth M. Simpson, University of British Columbia, Canada;
“Dynamic and customized iris embedded inside a scleral lens for aniridia patients”,
Andrés Vásquez Quintero, Assoc. Prof., Azalea Vision, Belgium;
“Innovations in sutureless transplantation of amniotic membrane for the outpatient management of ocular surface diseases”,
Andrew Hopkinson, Assoc. Prof., University of Nottingham, United Kingdom;
“New age-dependent aniridia-like mouse model”,
Karina Hadrian, PhD, University Hospital of Cologne, Germany;
“129S1/Svlmj Pax6 small-eye mice: A novel model for investigating innovative Aniridia Associated Keratopathy (AAK) therapies”,
Dina Javidjam, PhD candidate, Linköping university, Sweden
10.30 – 11.00
Moderators: James Lauderdale & Stefano Ferrari
Participants: Elizabeth M. Simpson, Andrés Vásquez Quintero, Andrew Hopkinson, Karina Hadrian & Dina Javidjam
11.00 – 11.30
11.30 – 12.00
12.00 – 12.15
Prof. Neil Lagali, Linköping university, Sweden
12.15 – 12.30
Scientific committee:
Branka Samolov, MD, PhD, S:t Erik eye hospital, Sweden;
Berit Byström, MD, Docent, Umeå university, Sweden;
Prof. Neil Lagali, Linköping university, Sweden;
Aniridia organizations:
Neven Milivojevic, Vice President of Aniridia Sweden;
Ivana Kildsgaard, President of Aniridia Sweden.
Barbara Poli, President of Aniridia Europe.
12.30
14.00
If you have questions, please do not hesitate to contact us.